Prism Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Hold
1,025
0.06% 64
2026
Q1
$251K Sell
1,025
-116
-10% -$27K 0.07% 64
2025
Q4
$236K Hold
1,141
0.06% 67
2025
Q3
$212K Buy
+1,141
New +$195K 0.06% 70
2022
Q4
Sell
-1,525
Closed -$249K 50
2022
Q3
$249K Hold
1,525
0.1% 46
2022
Q2
$271K Hold
1,525
0.1% 41
2022
Q1
$270K Hold
1,525
0.09% 42
2021
Q4
$261K Hold
1,525
0.09% 43
2021
Q3
$246K Hold
1,525
0.09% 45
2021
Q2
$251K Hold
1,525
0.09% 45
2021
Q1
$251K Sell
1,525
-263
-15% -$42.6K 0.09% 42
2020
Q4
$281K Hold
1,788
0.11% 40
2020
Q3
$266K Hold
1,788
0.11% 40
2020
Q2
$251K Hold
1,788
0.11% 40
2020
Q1
$234K Hold
1,788
0.15% 54
2019
Q4
$261K Hold
1,788
0.13% 55
2019
Q3
$231K Hold
1,788
0.13% 55
2019
Q2
$249K Sell
1,788
-176
-9% -$24.4K 0.14% 52
2019
Q1
$275K Buy
1,964
+176
+10% +$23.6K 0.16% 48
2018
Q4
$231K Hold
1,788
0.15% 49
2018
Q3
$248K Sell
1,788
-394
-18% -$52.4K 0.14% 50
2018
Q2
$274K Hold
2,182
0.15% 48
2018
Q1
$274K Hold
2,182
0.15% 47
2017
Q4
$305K Buy
+2,182
New +$304K 0.17% 42

Other funds holding JNJ

Prism Advisors's JNJ Position: Q2 2026 in Review

Prism Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,025 shares worth $260K. The position accounts for 0.06% of the portfolio, ranked #64.

Prism Advisors first reported a position in JNJ in Q4 2017 and has held it in 24 quarters since. The position peaked at $305K in Q4 2017. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Prism Advisors held 1,025 shares of Johnson & Johnson worth $260K as of Q2 2026.
  • Prism Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.06% of Prism Advisors's portfolio in Q2 2026, its #64 holding.
  • Prism Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 24 quarters since.
  • Prism Advisors's Johnson & Johnson position peaked at $305K in Q4 2017.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Prism Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.